DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Continued Examination Under 37 CFR 1.114
A request for continued examination under 37 CFR 1.114, including the fee set
forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this
application is eligible for continued examination under 37 CFR 1.114, and the fee set
forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action
has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on
November 7, 2025 has been entered.
Claim Rejections - 35 USC § 103
The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action.
Claims 12, 15, 26, 28, and 30, are rejected under 35 U.S.C. 103 as being unpatentable over Azechi (JP 2012122024 A, hereinafter referring to both the original Japanese version and the ESPACENET English translation) in view of Koshikawa-602 (US 2005/0090602 A1).
Regarding claim 12, Azechi teaches an adhesive sheet suitable for use as a masking material for painting applications ([0001]), comprising an adhesive layer ([0002]) made from a fluororesin gel ([0012]), comprising:
30 to 90 parts by mass of a linear perfluoropolyether compound having at least two alkenyl groups in one molecule and a perfluoropolyether structure in the main chain ([0012]), including hexafluoropropylene oxide groups (which read on the claimed “repeating unit represented by -CaF2aO-“ because hexafluoropropylene oxide groups fall within this representative structure when a is 3), which reads on the claimed component “(A)”. An amount of any single compound can be mathematically normalized to 100 parts by mass. Thus, any amount of this compound reads on the claimed “100 parts,” as long as the masses of the remaining components are similarly normalized such that the relative amounts of each compound are proportionally similar to the taught ranges.
An effective curing amount of an organosilicon compound having at least two hydrogen atoms bonded to silicon atoms in one molecule ([0012]), which reads on the claimed component “(B)”
A catalytic amount of a hydrosilylation reaction catalyst ([0012]), which reads on the claimed component “(C)”
Regarding the newly-added limitation requiring that the composition be free from a fluoromonoalkenyl compound having one alkenyl group per molecule and having a perfluoroether structure or perfluoropolyether structure in a main chain, Azechi differs from claim 12 because it teaches the incorporation of a pefluoromonoalkenyl compound having one alkenyl group in one molecule and a perfluoroether structure in the main chain ([0012]).
In the same field of endeavor, Koshikawa-602 teaches an adhesive composition
containing a linear perfluoropolyether, a fluorinated organohydrogensiloxane, and a
platinum catalyst (Abstract), and further teaches the incorporation of additional components including plasticizers, viscosity modifiers, and flexibilizers, of which
polyfluoromonoalkenyl compounds are a suitable option ([0092]). In addition to the
polyfluoromonoalkenyl compounds, Koshikawa-602 additionally teaches the optional
use of linear polyfluoro compounds, which do not have one alkenyl group in one molecule ([0092], [0094], and [0098]). It is prima facie obvious to substitute equivalents
known in the art as suitable for the same purpose (see MPEP 2144.06). Therefore, it
would have been obvious to one having ordinary skill in the art at the time of filing to
substitute the polyfluoromonoalkenyl compound of Azechi with a linear polyfluoro
compound of Koshikawa-602 (which does not contain one alkenyl group in one
molecule and which therefore does not fall under the purview of the excluded
compounds), as Koshikawa-602 recognizes said linear polyfluoro compounds as
suitable alternatives thereto.
In so doing, the formulation of Azechi as modified does not contain a
fluoromonoalkenyl compound having one akenyl group per molecule, and therefore
meets all of the compositional limitations of the claimed composition.
Azechi teaches that the composition preferably has an adhesive strength ranging from 0.5 to 5 N/25 mm ([0034]), which does not overlap the claimed range of “less than 0.5 N/25 mm. Nevertheless, Azechi teaches a composition whose adhesive strength lies very close to the upper limit of the claimed range. In cases where the claimed ranges or amounts do not overlap with the prior art but are merely close, a prima facie case of obviousness exists (See MPEP 2144.05.I.). Furthermore, the composition of Azechi as described above meets all of the compositional limitations of the claimed composition. Products of identical chemical compositions cannot have mutually exclusive properties. Where the claimed and prior art products are identical or substantially identical in structure or composition, a prima facie case of obviousness has been established. See MPEP 2112.01. The claimed adhesion characteristic will therefore necessarily be present in Azechi as applied above.
Regarding claim 15, Azechi teaches that the preferred linear perfluoropolyether compounds are those which are exactly the same as the claimed structures (see [0014] of both the translated and original Japanese versions of Azechi).
Regarding claim 26, Azechi teaches all of the limitations of claim 12 as described above. Azechi differs from claim 26 because it is silent with regard to the claimed volume resistivities. Nevertheless, Azechi as applied above results in a composition that is structurally identical to the claimed “adhesive composition,” which contains all of the same components in the same compositional amounts. Products of identical chemical compositions cannot have mutually exclusive properties. Where the claimed and prior art products are identical or substantially identical in structure or composition, a prima facie case of obviousness has been established. See MPEP 2112.01. The claimed volume resistivities will therefore necessarily be present in Azechi as applied to claim 12, above.
Regarding claim 28, Azechi teaches that the inventive formulation is used as an adhesive layer to be used in an adhesive sheet for paint applications ([0001]-[0002] and [0012]), which reads on the claimed “adhesive.”
Regarding claim 30, Azechi teaches that the inventive formulation is used as an adhesive layer to be used in an adhesive sheet for paint applications ([0001]-[0002] and [0012]), which reads on the claimed “tape” because the adhesive of Azechi is deposited onto a sheet of plastic (e.g., [0139]), and the overall invention is used as an adhesive sheet (i.e., a tape).
Response to Arguments
Applicant’s arguments, see Applicant’s Remarks, filed November 7, 2025, with respect to the rejections of claims 12, 15, 26, 28, and 30 under 35 USC 103 have been fully considered and are persuasive. Therefore, the rejection has been withdrawn. However, upon further consideration, a new grounds of rejection is made in view of Koshikawa-602, as described above.
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to JOSHUA CALEB BLEDSOE whose telephone number is (703)756-5376. The examiner can normally be reached Monday-Friday 8:00 a.m. - 5:00 p.m. EST.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert Jones can be reached at 571-270-7733. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/JOSHUA CALEB BLEDSOE/ Examiner, Art Unit 1762
/ROBERT S JONES JR/ Supervisory Patent Examiner, Art Unit 1762